Reimagine Medicine

Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…

Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…

Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites…

Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricingAdditional Novartis medicines will be…

Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients